Immunogen

After AbbVie's ImmunoGen buy, Elahere posts midstage trial win in ovarian cancer subtype
Fierce Pharma
Thu, 06/6/24 - 09:13 pm
AbbVie
antibody-drug conjugates
Elahere
Immunogen
Emergence of ADCs as the “hot, new technology”
Pharmaphorum
Thu, 04/25/24 - 11:39 am
antibody-drug conjugate
Immunogen
AbbVie
Seagen
Pfizer
cancer
M&A
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
oncology
M&A
AbbVie
Immunogen
Bristol Myers Squibb
Mirati Therapeutics
RayzeBio
Novartis
MorphoSys
AstraZeneca
Fusion Pharmaceuticals
JNJ
Ambrx
Gracell
AbbVie wraps up its $10.1B buyout of ImmunoGen well ahead of schedule
Fierce Pharma
Mon, 02/12/24 - 11:07 pm
AbbVie
Immunogen
M&A
Inside AbbVie's $10B buyout of ImmunoGen—and the bidding war it swooped in on
Fierce Pharma
Tue, 01/2/24 - 10:11 pm
AbbVie
Immunogen
M&A
antibody-drug conjugate
Sanofi’s oncology strategy suffers another blow as ADC scrapped over phase 3 lung cancer fail
Fierce Biotech
Thu, 12/21/23 - 09:40 am
Sanofi
antibody-drug conjugate
lung cancer
clinical trials
tusamitamab ravtansine
Immunogen
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Medical Marketing and Media
Fri, 12/1/23 - 09:43 am
biotech stocks
AbbVie
Immunogen
M&A
AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field
Fierce Pharma
Thu, 11/30/23 - 10:20 am
AbbVie
M&A
antibody-drug conjugate
Immunogen
Elahere
ovarian cancer
ImmunoGen Inks Cancer ADC Partnership with ImmunoBiochem
BioSpace
Tue, 07/25/23 - 08:43 pm
Immunogen
ImmunoBiochem
cancer
antibody-drug conjugate
ImmunoGen’s drug Elahere offers hope for ovarian cancer patients
Clinical Trials Arena
Wed, 05/17/23 - 10:50 pm
Immunogen
Elahere
clinical trials
platinum-resistant ovarian cancer
ovarian cancer
ImmunoGen reports positive top-line data from ovarian cancer therapy trial
Clinical Trials Arena
Thu, 05/4/23 - 09:17 am
Immunogen
clinical trial
ovarian cancer
platinum-resistant ovarian cancer
Elahere
Major readouts on the horizon for small developers
EP Vantage
Fri, 03/31/23 - 10:19 am
Aldeyra Therapeutics
Autolus Therapeutics
Bavarian Nordic
BioXcel Therapeutics
Disc Medicine
Editas Medicine
Immunogen
Lantheus
Mersana Therapeutics
NGM Biopharmaceuticals
Omeros
Roche
Sutro BioPharma
uniQure
Valneva
Viking Therapeutics
Vertex pays ImmunoGen $15M to use antibody-drug conjugates to improve CRISPR therapy
Fierce Biotech
Wed, 03/1/23 - 09:56 am
Vertex Pharmaceuticals
Immunogen
gen editing
antibody-drug conjugate
exa-cel
Biotech’s key upcoming clinical results
EP Vantage
Tue, 12/20/22 - 10:27 am
clinical trials
Acadia Pharmaceuticals
Argenx
Arrowhead Pharmaceuticals
Biomarin
BioNTech
Daiichi Sankyo
Day One
EQRx
Fate Therapeutics
FibroGen
Gilead Sciences
Idorsia
Immunogen
Intellia Therapeutics
Karuna Therapeutics
Moderna Therapeutics
Regeneron
Roche
Travere Therapeutics
Vaxcyte
FDA Action Alert: Spectrum, ImmunoGen, Scynexis and Y-mAbs
BioSpace
Mon, 11/21/22 - 10:06 am
FDA
Spectrum Pharmaceuticals
poziotinib
Immunogen
mirevtuximab soravtansine
Scynexis
Brexafemme
Y-mAbs
Omblastys
FDA bestows accelerated approval on ImmunoGen's ovarian cancer drug, with confirmatory answer coming soon
Endpoints
Tue, 11/15/22 - 10:41 am
Immunogen
FDA
ovarian cancer
mirvetuximab soravtansine
ImmunoGen commercial chief to withdraw before drug launch
Medical Marketing and Media
Fri, 11/4/22 - 10:27 am
Immunogen
mirvetuximab soravtansine
ovarian cancer
After chat with FDA, ImmunoGen delays pivotal top-line data on blood cancer ADC to 2024
Fierce Biotech
Wed, 08/31/22 - 10:31 am
Immunogen
antibody drug conjugate
pivekimab sunirine
blood cancer
ADC Space Continues to Thrive with Four More Companies Linking Up
BioSpace
Thu, 06/16/22 - 10:30 am
antibody-drug conjugate
Exelixis
Bioinvent
Oxford BioTherapeutics
Immunogen
Amid Waves of Biotech Layoffs, ADC Developers like ImmunoGen are Thriving
BioSpace
Mon, 05/9/22 - 09:58 am
layoffs
antibody-drug conjugate
Seagen
Immunogen

Pages